http://rdf.ncbi.nlm.nih.gov/pubchem/patent/YU-10493-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00
filingDate 1994-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee84d103f0eb2ffc9421dd8cb39e909d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_592a5882a55e2657b3a7574097256547
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbc29d97e515987fade5a207f6b1d2e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6595195530060a9f27eb3599154c0bfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad90e8c7c00910b68d24bb486fd9e37a
publicationDate 1996-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber YU-10493-A
titleOfInvention PROCEDURE FOR PREPARATION OF PROLINBORONATE ESTER
abstract PROCEDURE FOR PREPARATION OF PROLINBORONATE ESTER A process for the preparation of a prolineboronic acid ester is described. Lithium is introduced into the 2-position in the pyrrole (I) with the protected nitrogen atom. The lithium (II) compound was reacted with trialkyl borate to afford the protected pyrrole-2-boronic acid (III). It is reduced to give protected prolineboronic acid (IV) which further reacts with some diol to give ester (IV) With a boronic acid unit protected by an ester group, the protecting group is removed from the nitrogen atoms to give the desired proline ester -boronic acids (VII). According to an alternative method, lithium is introduced into the 2-position in protected pyrrolidine (VIII) to give protected 2-lithium pyrrolidine (IX). It reacts with trialkylborate and gives intermediate IV. The prolineboronic acid esters thus obtained have a chiral center adjacent to the boron atom. Methods for separating the enantiomers are also provided. The final products may be coupled to activated carboxylic acids to produce peptides containing the prolineboronic acid ester, instead of the amino acid, at the terminal C-atom. Such boronic acid peptide analogues are used to inhibit biologically relevant proteases. Several methods for separating pinandiol from pinandiol boronate esters are also provided.
priorityDate 1994-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421360175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21867279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3028194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431904250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410495873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4192668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551550
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410031093

Total number of triples: 31.